{
  "pmid": "36224326",
  "uid": "36224326",
  "title": "Reply to the letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial'.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Branch",
      "fore_name": "Kelley R H",
      "initials": "KRH",
      "name": "Kelley R H Branch",
      "affiliations": [
        "University of Washington Heart Institute, Seattle, WA, USA."
      ],
      "orcid": "0000-0003-2362-6498"
    },
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel C",
      "initials": "HC",
      "name": "Hertzel C Gerstein",
      "affiliations": [
        "Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, ONT, Canada."
      ]
    },
    {
      "last_name": "Probstfield",
      "fore_name": "Jeffrey L",
      "initials": "JL",
      "name": "Jeffrey L Probstfield",
      "affiliations": [
        "University of Washington Heart Institute, Seattle, WA, USA."
      ]
    }
  ],
  "journal": {
    "title": "European journal of heart failure",
    "iso_abbreviation": "Eur J Heart Fail",
    "issn": "1879-0844",
    "issn_type": "Electronic",
    "volume": "24",
    "issue": "11",
    "pub_year": "2022",
    "pub_month": "Nov"
  },
  "start_page": "2207",
  "end_page": "2208",
  "pages": "2207-2208",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Humans",
    "Heart",
    "Heart Failure",
    "Randomized Controlled Trials as Topic"
  ],
  "article_ids": {
    "pubmed": "36224326",
    "doi": "10.1002/ejhf.2719"
  },
  "doi": "10.1002/ejhf.2719",
  "dates": {
    "completed": "2022-12-15",
    "revised": "2025-04-07"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:22:49.739828",
    "pmid": "36224326"
  }
}